ANDA 206919, held by Eugia Pharma. Levofloxacin.
As of Nov 16, 2026, ANDA 206919 (Levofloxacin In Dextrose 5% In Plastic Container), held by Eugia Pharma, was first approved by FDA on Feb 10, 2016, with 5 approved supplements and 0 published complete response letters.
Levofloxacin injection is indicated for the treatment of adults (≥18 years of age) with mild, moderate, and severe infections caused by susceptible isolates of the designated microorganisms in the conditions listed in this section. Levofloxacin injection is indicated when intravenous administration offers a route of administration advantageous to the patient (e.g., patient cannot tolerate an oral dosage form). Levofloxacin injection is a fluoroquinolone antibacterial indicated in adults (≥18 years of age) with infections caused by designated, susceptible bacteria ( 1, 12.4 ). Pneumonia: Nosocomial and Community Acquired (1.2, 1.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 10, 2016 | Original application | Approved | None posted |
| Levofloxacin In Dextrose 5% In Plastic ContainerEQ 250MG/50ML (EQ 5MG/ML) · injectable;injection | Levofloxacin | Discontinued |
| Levofloxacin In Dextrose 5% In Plastic ContainerEQ 500MG/100ML (EQ 5MG/ML) · injectable;injection | Levofloxacin | Discontinued |
| Levofloxacin In Dextrose 5% In Plastic ContainerEQ 750MG/150ML (EQ 5MG/ML) · injectable;injection | Levofloxacin | Discontinued |
| Sep 20, 2024 | Supplement 9Labeling · Standard review | Approved | None posted |
| May 3, 2019 | Supplement 5Labeling · Standard review | Approved | None posted |
| Oct 18, 2018 | Supplement 4Labeling · Standard review | Approved | None posted |
| Oct 15, 2018 | Supplement 2Labeling · Standard review | Approved | None posted |
| Oct 15, 2018 | Supplement 3Labeling · Standard review | Approved | None posted |
| Feb 10, 2016 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters